Paola Fioretto

12PUBLICATIONS
31CO-AUTHORS
Molecular targetsCognitionPublic health nutritionGene and molecular therapyNephrology and urology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 02, 2026
The importance of treatment sequencing with SGLT2 inhibitors and GLP-1 receptor agonists combination for kidney function preservation in type 2 diabetes.

Mario Luca Morieri, Monica Vedovato, Benedetta Maria Bonora

|May 02, 2025
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc Analysis.

Peter Rossing, Andreas L Birkenfeld, Paola Fioretto

|Apr 03, 2024
Combination therapy for kidney disease in people with diabetes mellitus.

Daniël H van Raalte, Petter Bjornstad, David Z I Cherney

|Oct 28, 2023
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia.

Teresa Maria Seccia, Tungalagtamir Shagjaa, Margherita Morpurgo

|Dec 27, 2022
Potassium management with finerenone: Practical aspects.

Christoph Wanner, Paola Fioretto, Csaba P Kovesdy

|Mar 03, 2022
Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice.

Kamlesh Khunti, Serge Jabbour, Xavier Cos

Pageof 2

Frequent Collaborators

2 joint publications

Angelo Avogaro

2 joint publications

Gian Paolo Fadini

2 joint publications

Peter Rossing

1 joint publications

Stefano Del Prato